World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
13032
World Ranking
3422
National Ranking
11

Naoki Yamamoto publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Naoki Yamamoto sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 248 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Naoki Yamamoto D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Naoki Yamamoto sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Naoki Yamamoto is affiliated with the National University of Singapore in Singapore and has a research focus primarily in the field of Medicine. Their work spans several subfields, including Infectious Diseases, Epidemiology, Genetics, Surgery, and Molecular Biology.

The scientist has contributed to research on various topics, notably SARS-CoV-2 and COVID-19, with 20 publications related to the virus and disease. Additional main topics include COVID-19 Clinical Research Studies, Liver Disease Diagnosis and Treatment, Respiratory Viral Infections Research, Venous Thromboembolism Diagnosis and Management, Acute Ischemic Stroke Management, and Cancer, Hypoxia, and Metabolism.

Naoki Yamamoto has published in multiple scientific venues, with frequent contributions to:

  • arXiv (Cornell University)
  • Cureus
  • Scientific Reports
  • Biochemical and Biophysical Research Communications
  • Bioorganic & Medicinal Chemistry

Among recent papers by the researcher, notable publications include:

  • "Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro" (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • "SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype" (2020, Gene)
  • "VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration" (2020, Scientific Reports)
  • "Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation" (2020, Medical Hypotheses)
  • "Angiotensin-Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms" (2021, Genes)

Frequent collaborators of Naoki Yamamoto include Hajime Ikenouchi, Kunitada Shimotohno, Masashi Mizokami, Shin Urai, and Genzo Iguchi, with coauthorship counts ranging from five to seven papers.

Best Publications

  • Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

    Shinji Harada;Yoshio Koyanagi;Naoki Yamamoto

  • Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.

    Isao Sakaida;Shuji Terai;Naoki Yamamoto;Koji Aoyama

  • Constitutive Activation of NF-κB in Primary Adult T-Cell Leukemia Cells

    Naoki Mori;Masahiro Fujii;Shuichi Ikeda;Yasuaki Yamada

  • Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I–infected T-cell lines and primary adult T-cell leukemia cells

    Naoki Mori;Yasuaki Yamada;Shuichi Ikeda;Yoshihiro Yamasaki

  • Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4.

    R Kikukawa;Y Koyanagi;S Harada;N Kobayashi

  • Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.

    Y. Itoyama;S. Minato;Jun-Ichi Kira;I. Goto

  • Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.

    Y Hamamoto;H Nakashima;T Matsui;A Matsuda

  • Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]

    M Ito;H Nakashima;M Baba;R Pauwels

  • Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).

    Masahiko Ito;Akihiko Sato;Kazuhiro Hirabayashi;Fuminori Tanabe

  • Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae.

    H Nakashima;Y Kido;N Kobayashi;Y Motoki

  • Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax.

    Tomonori Tsukahara;Mari Kannagi;Takashi Ohashi;Hirotomo Kato

  • Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo

    Yuyou Duan;Andreea Catana;Ying Meng;Naoki Yamamoto

  • An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes

    Shuji Terai;Isao Sakaida;Naoki Yamamoto;Kaoru Omori

  • Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage.

    Hitoshi Shirahashi;Jian Wu;Naoki Yamamoto;Andreea Catana

  • Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives

    Susumu Shibahara;Sachiko Mukai;Hirokazu Morisawa;Hideki Nakashima

  • Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.

    Jun‐ichi ‐i Kira;Yoshio Koyanagi;Takeshi Yamada;Yasuto Itoyama

  • Tumor promoter, TPA, enhances replication of HTLV-III/LAV.

    Shinji Harada;Yoshio Koyanagi;Hideki Nakashima;Nobuyuki Kobayashi

  • Augmentation of Human Immunodeficiency Virus Type 1 Gene Expression by Tumor Necrosis Factor α

    Takashi Okamoto;Toshifumi Matsuyama;Shigehisa Mori;Yoshiaki Hamamoto

  • Mechanism of the Inhibitory Effect of Curdlan Sulfate on HIV-1 Infection in Vitro

    Paul P. Jagodzinski;Richard Wiaderkiewicz;Grzegorz Kurzawski;Marek Kloczewiak

  • Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells.

    Naoki Mori;Masahiro Fujii;Kousuke Iwai;Shuichi Ikeda

Frequent Co-Authors

Yoshio Koyanagi
Yoshio Koyanagi Kyoto University
Hiroshi Nishina
Hiroshi Nishina Tokyo Medical and Dental University
Naoki Mori
Naoki Mori University of the Ryukyus
Yorio Hinuma
Yorio Hinuma Kyoto University
Kiwamu Okita
Kiwamu Okita Yamaguchi University
Jun-ichi Kira
Jun-ichi Kira Kyushu University
Yuetsu Tanaka
Yuetsu Tanaka University of the Ryukyus
Mari Kannagi
Mari Kannagi Tokyo Medical and Dental University
Hirokazu Tamamura
Hirokazu Tamamura Tokyo Medical and Dental University
Kunitada Shimotohno
Kunitada Shimotohno National Center For Global Health and Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare and research careers, often requiring foundational knowledge in nursing and clinical practices. For those transitioning from non-medical backgrounds, exploring online absn programs for non nurses is a great starting point. These programs accelerate the process of becoming a registered nurse, combining nursing fundamentals with advanced immunology concepts.

If you're looking to fast-track your nursing credentials, accelerated nursing programs offer intensive coursework designed for quick completion. This can be particularly beneficial for students eager to enter immunology-related clinical roles or research positions.

For entry into practical nursing roles supporting immunology specialists, identifying the best easiest lpn programs to get into is crucial. Licensed Practical Nurses (LPNs) provide essential care and assist in clinical environments focused on immune system disorders.

Advancing further, becoming a Nurse Practitioner (NP) with immunology expertise often involves selecting from the easiest np programs to get into. These degrees prepare professionals for specialized roles managing immunological health concerns through direct patient care and treatment plans.

Best Scientists Citing Naoki Yamamoto

Trending Scientists

Recently Published Articles